Hereditary Breast and Ovarian Cancer Clinical Trial
Official title:
Evaluation of the Adhesion to the Network of Care of People at Genetic Risk of Cancer in Midi-Pyrénées (GENEPY)
In order to best meet the needs of all those affected by the genetic risk of cancer in our region, it is important to identify the factors likely to influence the course leading to the GENEPY surveillance network. The aim of this study is to evaluatie the adhesion to the network of care of people at genetic risk of cancer in Midi-Pyrénées (GENEPY).
This network has been open since November 2015 for people who are genetically predisposed to
breast / ovarian cancer. The extension to digestive pathologies (HNPCC syndrome, PAF) is in
progress. It concerns not only the persons carrying a mutation also those belonging to a
family without identified mutation but whose risk of predisposition is important.
The GENEPY network is based on a collaboration between oncogenetic consultations in the
region and professionals practicing in institutions (private, public) and liberal: general
practitioners, gynecologists, radiologists, oncologists, gastroenterologists, psychologists
...
It is therefore a multicentric and multidisciplinary network, which aims to promote the local
care of people genetically predisposed (or considered at high risk of genetic
predisposition), while ensuring a high level of competence, to guarantee an optimal and
equitable care on the whole of Midi Pyrenees.
The diagnosis of a new genetic disease in an individual is likely to have implications for
other family members who may themselves be at risk of developing the disease and / or passing
it on to their children.
The inclusion of subjects in the GENEPY network follows the genealogical study of a case
(index) : relatives are identified as potentially at risk. In accordance with the
recommendations, but also generally at the wish of the patients, the index case is then asked
to inform its relatives and to propose them to go to an oncogenetic consultation of their
choice. If these people reside in the Midi Pyrenees Toulouse oncogenetic consultation is open
to them. If following this consultation a mutation is identified or that their genetic risk
is considered important, they are proposed to join the GENEPY network for their monitoring.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03246841 -
Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.
|
N/A | |
Completed |
NCT03421327 -
Genetic Risk: Whether, When, and How to Tell Adolescents
|
||
Terminated |
NCT04668521 -
Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection
|
||
Completed |
NCT03075540 -
Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer
|
N/A | |
Enrolling by invitation |
NCT05721326 -
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
|
N/A | |
Recruiting |
NCT04407611 -
Scalable Communication Modalities for Returning Genetic Research Results
|
N/A | |
Recruiting |
NCT02302742 -
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
|
||
Recruiting |
NCT02516540 -
Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers
|
N/A | |
Recruiting |
NCT05409222 -
Study of Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2 Mutation Carriers (BRCA-HRT)
|
||
Completed |
NCT02324062 -
Cancer Genetics Hereditary Cancer Panel Testing
|
N/A | |
Enrolling by invitation |
NCT05130606 -
CONTIGO - Informing Latinas About HBOC Risk
|
N/A | |
Completed |
NCT03511690 -
Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment
|
N/A | |
Completed |
NCT02087592 -
Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers
|
N/A | |
Active, not recruiting |
NCT01608074 -
Radical Fimbriectomy for Young BRCA Mutation Carriers
|
N/A | |
Terminated |
NCT04508764 -
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
|
N/A | |
Recruiting |
NCT03050268 -
Familial Investigations of Childhood Cancer Predisposition
|
||
Completed |
NCT02786147 -
Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer
|
||
Recruiting |
NCT03124212 -
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
|